Nilay Shah, MD
Clinical Neurophysiology · Maywood, NJNPI 1154372621
Payments from drug & device makers
Across 1,524 payments — averaging $278.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$199K
- TG Therapeutics, Inc.$121K
- E.r. Squibb & Sons, L.L.C.$32K
- SK Life Science, Inc.$27K
- ANI Pharmaceuticals, Inc.$8K
- Novartis$7K
- plus $30K from 54 others
What the payments were for
- Consulting fees$7,5102%
- Speaking & faculty fees$332,56980%
- Travel & lodging$43,14310%
- Food & beverage$32,1048%
- Education$840%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mavenclad$181,554
- BRIUMVI$120,419
- ZEPOSIA$33,935
- XCOPRI$25,676
- PURIFIED CORTROPHIN GEL$7,035
- Rebif$5,600
- ACTHAR$5,178
- Albuked$4,000
- KOATE$4,000
- GAMMAKED$4,000
- KEDRAB$4,000
- RhoGAM Ultra-Filtered PLUS$4,000
- INFINITY$1,317
- VNS Therapy$893
- GENERAL DBS$424
- Symbravo$384
- Ponvory$375
- VALTOCO$230
- TYSABRI$150
- NURTEC ODT$144
How this compares
Too few clinical neurophysiology providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 463 | $10,703,062 |
| GammaplexImmun Glob G(Igg)/Gly/Iga 0-50 | 355 | $7,819,596 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 120 | $3,560,735 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 56 | $1,011,463 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 54 | $973,890 |
| ZeposiaOzanimod Hydrochloride | 19 | $257,937 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 11 | $194,568 |
| Kesimpta PenOfatumumab | 12 | $103,146 |
| XcopriCenobamate | 55 | $61,605 |
| Nurtec OdtRimegepant Sulfate | 42 | $53,233 |
| ValtocoDiazepam | 18 | $29,427 |
| Memantine Hcl | 359 | $10,840 |
| AmantadineAmantadine Hcl | 76 | $4,927 |
| Levetiracetam | 106 | $4,154 |
| Gabapentin | 230 | $4,049 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerOctagam, Nurtec Odt | $440 | $10,756,295505 claims |
| Kedrion Biopharma, Inc.Gammaked | $4,000 | $3,560,735120 claims |
| CSL BehringPrivigen, Hizentra | $459 | $1,206,03167 claims |
| Grifols USA, LLCGamunex-C | $53 | $973,89054 claims |
| E.r. Squibb & Sons, L.L.C.Zeposia | $32,424 | $257,93719 claims |
| SK Life Science, Inc.Xcopri | $27,022 | $61,60555 claims |
| Neurelis, Inc.Valtoco | $507 | $29,42718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical neurophysiology providers in New Jerseyon file to place this against a meaningful peer group, so we don't.
Other clinical neurophysiology in Maywood
- Lydia ShajenkoEdgewater$85K
- Volker KnappertzMorristown$68K
- Iman YoussefEgg Harbor Twp$9K
- Andy RodriguezLivingston$8K
- Tom NoffCamden$3K
- Chirag ShuklaHamilton$2K
- Robert AngelsHackensack$725
- Lorraine LazarMorristown$419
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.